DIAGENS
Latest round
- Series C
Last raised
- Dec 2023
Total raised
- $30M
Investors
- 7
About DIAGENS
, trading as DIAGENS, is a medical equipment company focusing on the reproductive field. The company has built R&D, exhibition, office, and GMP production sites of nearly 50,000 square meters, and has undertaken 8 national and provincial-level research projects. It acquired CE certification from the European Union, with more than 40 intellectual property rights in the United States, Europe, China, and other places. The company established cooperation with universities, such as Zhejiang University, Shanghai Jiaotong University, and Central South University. The company's products can be divided into Auto Vision Intelligent chromosome karyotype analysis system, the first generation cell culture medium, assisted reproduction consumables, MetaSight automatic cell microscopic image scanning system, and cytogenetics reagents. The Auto Vision Intelligent chromosome karyotype analysis system and MetaSight automatic cell microscopic image scanning system were used by dozens of tertiary hospitals for analysis. The assisted reproduction consumable products include microinjection needles, special dishes for micro-fertilization, embryo freezing, and resuscitation fluids. The company generates revenue by selling AI-powered medical imaging software, medical diagnostic devices, and related laboratory reagents and consumables to hospitals and clinical laboratories.
Who invested in DIAGENS
7 investors across 4 rounds
See all investors in DIAGENS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about DIAGENS
Who invested in DIAGENS?
DIAGENS has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DIAGENS raised?
DIAGENS has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did DIAGENS last raise money?
DIAGENS's most recent round on record is a Series C, in Dec 2023.
What does DIAGENS do?
, trading as DIAGENS, is a medical equipment company focusing on the reproductive field.
Where is DIAGENS headquartered?
DIAGENS is headquartered in Hangzhou, China.
Which VCs invest in companies like DIAGENS?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at DIAGENS's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like DIAGENS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.